Induction of tolerance after establishment of peanut allergy by the food allergy herbal formula-2 is associated with up-regulation of interferon-γ

被引:68
作者
Qu, C.
Srivastava, K.
Ko, J.
Zhang, T. F.
Sampson, H. A.
Li, X.-M.
机构
[1] Mt Sinai Sch Med, Dept Pediat, Div Allergy Immunol, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Med, Div Clin Immunol, New York, NY 10029 USA
关键词
chinese herbal medicine formula; peanut anaphylaxis; Th-2 cytokine modulation;
D O I
10.1111/j.1365-2222.2007.02718.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background Peanut (PN)-anaphylaxis is potentially life threatening. We previously reported that a Chinese herbal medicine preparation, food allergy herbal formula-2 (FAEF-2), prevented peanut allergy (PNA) in mice when administered during sensitization. Objective To investigate whether FAFIF-2 also can prevent anaphylactic reactions administered to mice with established PNA and, if so, whether protection would persist after cessation of therapy. Methods C3H/HeJ mice sensitized and boosted over 8 weeks with a standard protocol known to establish PN hypersensitivity received seven weeks of FAHF-2 treatment or water as a sham treatment. Mice were subsequently challenged with PN at week 14 (1-day post-therapy) and week 18 (4-week post-therapy) to evaluate the efficacy and persistence of FAEF-2 treatment by assessing anaphylactic scores, core body temperatures and plasma histamine levels. Serum PN-specific antibody levels and cytokine profiles from splenocytes and mesenteric lymph node (MLN) cells were also determined. Results All sham-treated mice challenged at weeks 14 and 18 showed anaphylactic symptoms. In contrast, FAEF-2-treated mice showed no sign of anaphylactic reactions. PN-specific IgE levels in FAHF-2-treated mice also were reduced whereas IgG2a levels were increased. Furthermore, MLN cells from FAHF-2-treated mice produced markedly less IL-4 and IL-5, but more IFN-gamma, and contained increased numbers of IFN-gamma-producing CD8(+) cells as compared with sham-treated mice. Conclusion FAHF-2 treatment established PN tolerance in this model, which persisted for at least 4-week post-treatment. This result was associated with modulation of intestinal T helper type 1 cell (Th 1) and Th2 cytokine production, and with increased numbers of mesenteric IFN-gamma-producing CD8(+) cells.
引用
收藏
页码:846 / 855
页数:10
相关论文
共 49 条
[1]   IL-10: a key regulator of allergic disease [J].
Barnes, PJ .
CLINICAL AND EXPERIMENTAL ALLERGY, 2001, 31 (05) :667-669
[2]   Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy [J].
Bashir, MEH ;
Louie, S ;
Shi, HN ;
Nagler-Anderson, C .
JOURNAL OF IMMUNOLOGY, 2004, 172 (11) :6978-6987
[3]   An enteric helminth infection protects against an allergic response to dietary antigen [J].
Bashir, MEH ;
Andersen, P ;
Fuss, IJ ;
Shi, HN ;
Nagler-Anderson, C .
JOURNAL OF IMMUNOLOGY, 2002, 169 (06) :3284-3292
[4]   Effects of cooking methods on peanut allergenicity [J].
Beyer, KB ;
Morrow, E ;
Li, XM ;
Bardina, L ;
Bannon, GA ;
Burks, AW ;
Sampson, HA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (06) :1077-1081
[5]   Fatalities due to anaphylactic reactions to foods [J].
Bock, SA ;
Muñoz-Furlong, A ;
Sampson, HA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (01) :191-193
[6]  
Brandtzaeg P, 2002, ANN NY ACAD SCI, V964, P13
[7]   IDENTIFICATION AND CHARACTERIZATION OF A 2ND MAJOR PEANUT ALLERGEN, ARA H II, WITH USE OF THE SERA OF PATIENTS WITH ATOPIC-DERMATITIS AND POSITIVE PEANUT CHALLENGE [J].
BURKS, AW ;
WILLIAMS, LW ;
CONNAUGHTON, C ;
COCKRELL, G ;
OBRIEN, TJ ;
HELM, RM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 90 (06) :962-969
[8]   Differential efficacy of a synthetic antagonist of VLA-4 during the course of chronic relapsing experimental autoimmune encephalomyelitis [J].
Cannella, B ;
Gaupp, S ;
Tilton, RG ;
Raine, CS .
JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 71 (03) :407-416
[9]  
De Jong EC, 1998, CLIN EXP ALLERGY, V28, P743, DOI 10.1046/j.1365-2222.1998.00301.x
[10]   Bioactive molecules in milk and their role in health and disease:: The role of transforming growth factor-β [J].
Donnet-Hughes, A ;
Duc, N ;
Serrant, P ;
Vidal, K ;
Schiffrin, EJ .
IMMUNOLOGY AND CELL BIOLOGY, 2000, 78 (01) :74-79